Neoplasms Metastasis Terminated Phase 2 Trials for Talabostat (DB06182)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00116389Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the PancreasTreatment